Diabetic macular oedema - Fluocinolone acetonide intravitreal implant (rapid review of TA271): evaluation report

Please be advised that the format of evaluation reports shared on the NICE website has recently changed, for ease of user navigation between individual documents contained in the report.

It is a requirement of the new (PDF portfolio) format that Adobe Reader is used to view the document. Please follow the link at the bottom of this page to download Adobe Reader if required.

If you have any feedback on the new format please contact the Project Manager for this appraisal.

Diabetic macular oedema - Fluocinolone acetonide intravitreal implant (rapid review of TA271): evaluation report

01 - PAS submission from the technology manufacturer - Alimera Sciences 

02 - Department of Health PAS approval letter 

03 - Evidence Review Group report prepared by Warwick evidence

This page was last updated: 13 June 2013